Health
FDA authorizes marketing of a new device for use in patients undergoing stroke rehabilitation – News-Medical.Net
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation to…
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation to facilitate muscle re-education and for maintaining or increasing range of motion. The Neurolutions IpsiHand Upper Extremity Rehabilitation System (IpsiHand System) is a Brain-Computer-Interface (BCI) device that assists in rehabilitation for stroke patients with upper extremity—or hand, wrist and arm—disability.
Thousands of stroke survivors…
-
Noosa News8 hours agoHow Lily Steele-Park took her rapist to court and won
-
General21 hours ago‘Potential’ hacker contacts Qantas over data breach
-
General23 hours agoFears for next anti-Semitic firebombing on home soil
-
Business12 hours agoFord CEO makes stunning prediction about artificial intelligence